QTC intervals can be assessed with the AliveCor heart monitor in patients on dofetilide for atrial fibrillation

被引：9

作者：

Muhlestein, Joseph B. ^{[1
]}

机构：

[1] Intermt Heart Inst, Salt Lake City, UT 84157 USA

来源：

JOURNAL OF ELECTROCARDIOLOGY | 2015年 / 48卷 / 01期

关键词：

AliveCor; Atrial fibrillation; ECG; QT interval; QTC;

D O I：

10.1016/j.jelectrocard.2014.11.007

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We assessed the feasibility of AliveCor tracings for QTC assessment in patients receiving dofetilide. Five patients with persistent AF underwent the two-handed measurement (mimicks Lead I). On the ECG, Lead I or II was used. There was no significant difference between the AliveCor-QTC and ECG-QTC (all +/- 20 msec). The AliveCor device can be used to monitor the QTC in these patients. (C) 2015 Elsevier Inc. All rights reserved.

引用

页码：10 / 11

页数：2